About Cherwell Laboratories

Andy Whittard - Managing Director

At Cherwell we are part of a really important supply chain, at the end of which is a patient, trusting the healthcare professionals and treatments prescribed for their recovery. The drugs our clients manufacture must meet exacting standards and our products help them ensure these standards are met, every day.

We are ambitious; our 5 year strategy is named Accelerate – a change in velocity and our mission is to be the first company the pharma industry thinks of for cleanroom microbiology - the go to provider.

To realise this ambition we need great people. We already have a fantastic team; however, our ambitious growth plans mean we will need more people to fulfil an ever expanding variety of roles.

To achieve our ambitions over the next five years will require renewed energy and desire from our people, individuals who want to make a difference and help us on our journey.

Life at Cherwell can be fun and rewarding, we have a strong sense of caring - we are a friendly group with an open, accessible culture. Like any business we have challenges and sometimes we can be a little restrained and reactive. A key factor for our future success is picking up the pace of change and being more proactive. There will be opportunity to help shape the future of the business and to help design and implement new ways of working.

And Cherwell is now embarking on the next phase of its journey. In late 2023 we were acquired by AnalytiChem Holding GmbH and joined seven other dynamic businesses serving the life science sectors across Europe, North America, and Australia. Two other companies in the group also manufacture prepared media, presenting opportunities for collaboration and learning.

It is exciting times for Cherwell and the team!